Tumor-originated iOPN may promote tumor cell survival by preventing tumor-related protein 53 (TP53)-mediated apoptosis, whereas tumor-derived sOPN may function in a paracrine mode to accelerate lung metastasis by enhancing tumor-derived CCL2 chemokine signaling to cognate host receptors [139]. The gene discussed is CCL2; the disease is neoplasm.